Trials / Completed
CompletedNCT00927641
HKT-500 in the Treatment of Adult Patients With Ankle Sprain
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.
Detailed description
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Mild to Moderate Ankle Sprain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketoprofen Patch | Two Ketoprofen HKT-500 patches applied to target ankle once daily for 14 days |
| OTHER | Placebo Patch | Two placebo patches placed on target ankle once daily for 14 days |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-06-25
- Last updated
- 2015-06-04
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00927641. Inclusion in this directory is not an endorsement.